American Association for Cancer Research
Browse
00085472can114208-sup-fig2.pdf (394.48 kB)

Supplementary Figure 2 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis

Download (394.48 kB)
journal contribution
posted on 2023-03-30, 21:34 authored by Chris W. Doornebal, Sjoerd Klarenbeek, Tanya M. Braumuller, Christiaan N. Klijn, Metamia Ciampricotti, Cheei-Sing Hau, Markus W. Hollmann, Jos Jonkers, Karin E. de Visser

PDF file - 394K, S2. Genomic profiles of K14cre;Cdh1F/F;Trp53F/F derived donor mILCs are highly conserved in transplanted recipient outgrowths.

History

ARTICLE ABSTRACT

Metastatic disease accounts for more than 90% of cancer-related deaths, but the development of effective antimetastatic agents has been hampered by the paucity of clinically relevant preclinical models of human metastatic disease. Here, we report the development of a mouse model of spontaneous breast cancer metastasis, which recapitulates key events in its formation and clinical course. Specifically, using the conditional K14cre;Cdh1F/F;Trp53F/F model of de novo mammary tumor formation, we orthotopically transplanted invasive lobular carcinoma (mILC) fragments into mammary glands of wild-type syngeneic hosts. Once primary tumors were established in recipient mice, we mimicked the clinical course of treatment by conducting a mastectomy. After surgery, recipient mice succumbed to widespread overt metastatic disease in lymph nodes, lungs, and gastrointestinal tract. Genomic profiling of paired mammary tumors and distant metastases showed that our model provides a unique tool to further explore the biology of metastatic disease. Neoadjuvant and adjuvant intervention studies using standard-of-care chemotherapeutics showed the value of this model in determining therapeutic agents that can target early- and late-stage metastatic disease. In obtaining a more accurate preclinical model of metastatic lobular breast cancer, our work offers advances supporting the development of more effective treatment strategies for metastatic disease. Cancer Res; 73(1); 353–63. ©2012 AACR.